» Articles » PMID: 37353603

Rapidly Adaptable Automated Interpretation of Point-of-care COVID-19 Diagnostics

Abstract

Background: Point-of-care diagnostic devices, such as lateral-flow assays, are becoming widely used by the public. However, efforts to ensure correct assay operation and result interpretation rely on hardware that cannot be easily scaled or image processing approaches requiring large training datasets, necessitating large numbers of tests and expert labeling with validated specimens for every new test kit format.

Methods: We developed a software architecture called AutoAdapt POC that integrates automated membrane extraction, self-supervised learning, and few-shot learning to automate the interpretation of POC diagnostic tests using smartphone cameras in a scalable manner. A base model pre-trained on a single LFA kit is adapted to five different COVID-19 tests (three antigen, two antibody) using just 20 labeled images.

Results: Here we show AutoAdapt POC to yield 99% to 100% accuracy over 726 tests (350 positive, 376 negative). In a COVID-19 drive-through study with 74 untrained users self-testing, 98% found image collection easy, and the rapidly adapted models achieved classification accuracies of 100% on both COVID-19 antigen and antibody test kits. Compared with traditional visual interpretation on 105 test kit results, the algorithm correctly identified 100% of images; without a false negative as interpreted by experts. Finally, compared to a traditional convolutional neural network trained on an HIV test kit, the algorithm showed high accuracy while requiring only 1/50th of the training images.

Conclusions: The study demonstrates how rapid domain adaptation in machine learning can provide quality assurance, linkage to care, and public health tracking for untrained users across diverse POC diagnostic tests.

Citing Articles

Rapid and automated interpretation of CRISPR-Cas13-based lateral flow assay test results using machine learning.

Xue M, Gonzalez D, Osikpa E, Gao X, Lillehoj P Sens Diagn. 2025; 4(2):171-181.

PMID: 39817182 PMC: 11726308. DOI: 10.1039/d4sd00314d.


Efficacy of the mLab App: a randomized clinical trial for increasing HIV testing uptake using mobile technology.

Schnall R, Scherr T, Kuhns L, Janulis P, Jia H, Wood O J Am Med Inform Assoc. 2024; 32(2):275-284.

PMID: 39560363 PMC: 11756647. DOI: 10.1093/jamia/ocae261.


Measuring the performance of computer vision artificial intelligence to interpret images of HIV self-testing results.

Roche S, Ekwunife O, Mendonca R, Kwach B, Omollo V, Zhang S Front Public Health. 2024; 12:1334881.

PMID: 38384878 PMC: 10880864. DOI: 10.3389/fpubh.2024.1334881.

References
1.
Mendels D, Dortet L, Emeraud C, Oueslati S, Girlich D, Ronat J . Using artificial intelligence to improve COVID-19 rapid diagnostic test result interpretation. Proc Natl Acad Sci U S A. 2021; 118(12). PMC: 7999948. DOI: 10.1073/pnas.2019893118. View

2.
Zeng N, Wang Z, Li Y, Du M, Liu X . Inference of nonlinear state-space models for sandwich-type lateral flow immunoassay using extended Kalman filtering. IEEE Trans Biomed Eng. 2011; 58(7):1959-66. DOI: 10.1109/TBME.2011.2106502. View

3.
Kong J, Wei Q, Tseng D, Zhang J, Pan E, Lewinski M . Highly Stable and Sensitive Nucleic Acid Amplification and Cell-Phone-Based Readout. ACS Nano. 2017; 11(3):2934-2943. DOI: 10.1021/acsnano.6b08274. View

4.
Onur I, Velamuri M . The gap between self-reported and objective measures of disease status in India. PLoS One. 2018; 13(8):e0202786. PMC: 6110485. DOI: 10.1371/journal.pone.0202786. View

5.
Ibitoye M, Frasca T, Giguere R, Carballo-Dieguez A . Home testing past, present and future: lessons learned and implications for HIV home tests. AIDS Behav. 2013; 18(5):933-49. PMC: 3988264. DOI: 10.1007/s10461-013-0668-9. View